For Clinicians
The HDL Paradox: Why Raising HDL-C Wasn't Enough
Higher HDL-C has long been associated with lower cardiovascular risk. Yet therapies that raise HDL-C have largely failed to improve outcomes. What did we misunderstand about HDL biology, causality, and cardiovascular prevention?